BVF-Biovail Stock Research, Ratings, and Analysis

Biovail (bvf) Stock Research

Last Updated by WikiWealth | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Long Term Rating Stock Ratings Help

HOLD

SWOT Statistics bvf SWOT Analysis

Strengths + Opportunities = 2

Threats + Weaknesses = 0

Add your knowledge to the Biovail SWOT analysis.

Generic Strategy bvf Generic Strategy

Narrow Scope

Broad Scope

None

Uniqueness

Low Cost

Generic strategies categorize companies by the scope and the strength of their business. Biovail does not have a definable strategy, therefore, it risks losing out to firms that concentrate on one particular competitive advantage. (read more).

Company Description: The Biovail Corporation, founded in 1983, engages in the formulation, clinical testing, registration, manufacturing, and commercialization of pharmaceutical products utilizing various drug-delivery technologies as well offering clinical tril and ressearch services to third party companies in the United States and Canada. Update

Market Research Update

Health Care Industry Research & Analysis: The health care industry depends on the care of health-related services by professionals for the benefit of patients. Medical device markers, insurance companies, pharmaceutical drug developers and government institutions are major participants in the treatment of sick, injured and disabled patients. Health Care Trading Strategy: Health Care stocks tend to be less sensitive to economic changes. Look for undervalued health care investments at any point in the business cycle when stock prices are low. However, biotech, employment staffing and insurance companies may all decrease during recessions for different reasons. Government intervention is another important factor in health care investments, since government spending in health care is a very large portion of overall health care spending. When governments change spending plans, different sub-sectors in the industry are significantly affected. Upward sloping stock charts and financial news may indicate a selling opportunity while the opposite means that stocks are becoming undervalued.

Industry Sub Sector: .

Market Challenges: Opportunities: Solutions:

Strategy Analysis Update

Strategy: Competitive Advantages:

Financial Analysis Update

Complicated financial statements lower Biovail's value, because it increases the risk of fraud and lowers investor confidence.

Current Revenue Sources: Future Revenue Sources: